CSL (HAM:CSJ) Operating Margin %: 23.53% (As of Dec. 2025) — 13% Above Median


HAM:CSJ CSL Ltd HAM:CSJ
73 GF Score
Price €68.23
GF Value €170.71
Valuation Significantly Undervalued
! 7 Warning Signs
View Full Analysis

What is CSL Operating Margin %?

CSL HAM:CSJ +0.07% 73 Operating Margin % is 23.53% as of Dec. 2025, which is 13% above its 10-year median of 20.87. GuruFocus rates HAM:CSJ with a GF Score™ of 73/100 and a GF Value™ of €170.71 (Significantly Undervalued). The stock has 7 warning signs investors should review. Among 945 Biotechnology companies, CSL ranks better than 90.16% on this metric.

Operating Margin % is calculated as Operating Income divided by its Revenue. CSL's Operating Income for the six months ended in Dec. 2025 was €1,626 Mil. CSL's Revenue for the six months ended in Dec. 2025 was €6,911 Mil. Therefore, CSL's Operating Margin % for the quarter that ended in Dec. 2025 was 23.53%.

Warning Sign:

CSL Ltd operating margin has been in a 5-year decline. The average rate of decline per year is -6.8%.

The historical rank and industry rank for CSL's Operating Margin % or its related term are showing as below:

HAM:CSJ' s Operating Margin % Range Over the Past 10 Years
Min: 15.96   Med: 20.87   Max: 25.23
Current: 23.53


HAM:CSJ's Operating Margin % is ranked better than
90.16% of 945 companies
in the Biotechnology industry
Industry Median: -86.77 vs HAM:CSJ: 23.53

CSL's 5-Year Average Operating Margin % Growth Rate was -6.80% per year.

CSL's Operating Income for the six months ended in Dec. 2025 was €1,626 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2025 was €1,626 Mil.


CSL  (HAM:CSJ) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


CSL Operating Margin % Related Terms


CSL Operating Margin % Historical Data

* Premium members only.

The historical data trend for CSL's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CSL Operating Margin % Chart

CSL Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.23 22.07 15.96 18.82 19.18

CSL Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Jun25 Dec25
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.47 24.79 12.04 0.00 23.53

HAM:CSJ vs VRTX, REGN, ALNY: Operating Margin % Comparison

For the Biotechnology subindustry, CSL's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CSL Operating Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CSL's Operating Margin % distribution charts can be found below:

* The bar in red indicates where CSL's Operating Margin % falls into.


HAM:CSJ
73GF Score
CSL Ltd HAM:CSJ
Operating Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CSL Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

CSL's Operating Margin % for the fiscal year that ended in Jun. 2025 is calculated as

Operating Margin %=Operating Income (A: Jun. 2025 ) / Revenue (A: Jun. 2025 )
=2565.453 / 13377.81
=19.18 %

CSL's Operating Margin % for the quarter that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2025 ) / Revenue (Q: Dec. 2025 )
=1626.016 / 6910.568
=23.53 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of 23.53% mean?
CSL (HAM:CSJ) has a Operating Margin % of 23.53% as of Dec. 2025. Operating margin is the ratio of total operating income to net sales. View historical data on CSL and its competitors. This is 13% above median its historical median of 20.87. Over the past decade, CSL's Operating Margin % has ranged from 15.96 to 25.23. According to the industry distribution chart, CSL ranks #93 out of 945 companies in the Biotechnology industry, placing it in the top 9.8%.
Is CSL's Operating Margin % too high?
CSL's current Operating Margin % of 23.53% is 13% above median its 10-year median of 20.87. Over the past 10 years, this metric has ranged from a low of 15.96 to a high of 25.23. Based on the distribution chart, CSL ranks #93 out of 945 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, CSL has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CSL's Operating Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, CSL ranks #93 out of 945 companies for Operating Margin %. This places CSL in the top 10% of its industry — outperforming the majority of peers. Historically, CSL's own Operating Margin % has ranged from 15.96 to 25.23 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Biotechnology company?
A good Operating Margin % depends on the Biotechnology industry context. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on CSL and its competitors. CSL's current Operating Margin % is 23.53%, which is 13% above median its own 10-year median of 20.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CSL stock overvalued right now?
Based on GuruFocus' analysis, CSL (HAM:CSJ) is currently considered Significantly Undervalued. The stock's GF Value™ is €170.71, compared to a current price of €68.23 — trading 60% below its estimated fair value. The current Operating Margin % is 23.53%, which is 13% above median its 10-year median of 20.87. CSL's overall GF Score™ is 73/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For CSL (HAM:CSJ), the current Operating Margin % is 23.53% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CSL (HAM:CSJ) Overvalued in 2026?

Based on GuruFocus' analysis, CSL stock appears to be undervalued. The current stock price of €68.23 is trading 60% below its estimated GF Value™ of €170.71. GuruFocus considers CSL to be Significantly Undervalued.

Key valuation signals for HAM:CSJ:

  • Operating Margin %: 23.53% (13% above median its 10-year median of 20.87)
  • GF Value™: €170.71 vs. price of €68.23 (60% below fair value)
  • GF Score™: 73/100 with 7 warning signs

No single metric tells the full story. See the HAM:CSJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


CSL Business Description

Address 655 Elizabeth Street, Melbourne, VIC, AUS, 3000
CSL is one of the largest global biotech companies and has three main segments. CSL Behring either uses plasma-derived proteins or recombinants to treat conditions including immunodeficiencies, bleeding disorders, and neurological indications. CSL Seqirus is the world's second-largest influenza vaccination business and was acquired in fiscal 2016. CSL Vifor is an iron deficiency and nephrology business and was acquired in fiscal 2023. CSL has a strong R&D track record, and the product portfolio and pipeline include nonplasma products as the firm continues to broaden its scope. Originally formed in Australia as a government-owned entity, CSL now earns roughly half its revenue in North America and a quarter in Europe.
73GF Score

Get the complete analysis for HAM:CSJ

Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€68.23
Price
€170.71
GF Value